These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18344692)

  • 1. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection.
    Tellez I; Barragán M; Franco-Paredes C; Petraro P; Nelson K; Del Rio C
    Am J Med Sci; 2008 Mar; 335(3):192-7. PubMed ID: 18344692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.
    Radhi S; Alexander T; Ukwu M; Saleh S; Morris A
    BMC Infect Dis; 2008 Sep; 8():118. PubMed ID: 18796158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia.
    Morris A; Wachter RM; Luce J; Turner J; Huang L
    AIDS; 2003 Jan; 17(1):73-80. PubMed ID: 12478071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.
    Miller RF; Allen E; Copas A; Singer M; Edwards SG
    Thorax; 2006 Aug; 61(8):716-21. PubMed ID: 16601092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.
    Lee SH; Kim KH; Lee SG; Chen DH; Jung DS; Moon CS; Park JY; Chung JS; Kwak IS; Cho GJ
    J Korean Med Sci; 2013 Jan; 28(1):67-73. PubMed ID: 23341714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries.
    Llibre JM; Revollo B; Vanegas S; Lopez-Nuñez JJ; Ornelas A; Marin JM; Santos JR; Marte P; Morera M; Zuluaga P; Tor J; Clotet B
    Scand J Infect Dis; 2013 Aug; 45(8):635-44. PubMed ID: 23547568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
    Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
    AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era.
    Pulvirenti J; Herrera P; Venkataraman P; Ahmed N
    AIDS Patient Care STDS; 2003 Jun; 17(6):261-5. PubMed ID: 12880489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
    Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
    Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
    Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
    Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
    Wolff AJ; O'Donnell AE
    Chest; 2001 Dec; 120(6):1888-93. PubMed ID: 11742918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.
    Dore GJ; Li Y; McDonald A; Ree H; Kaldor JM;
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):388-95. PubMed ID: 11917244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era.
    Kim B; Lyons TM; Parada JP; Uphold CR; Yarnold PR; Hounshell JB; Sipler AM; Goetz MB; DeHovitz JA; Weinstein RA; Campo RE; Bennett CL
    J Gen Intern Med; 2001 Sep; 16(9):583-9. PubMed ID: 11556938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HAART on causes of death of persons with late-stage AIDS.
    Sansone GR; Frengley JD
    J Urban Health; 2000 Jun; 77(2):166-75. PubMed ID: 10855998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pneumocystis jiroveci pneumonia characteristics in adults with AIDS with or without antiretroviral therapy].
    Bahamondes M L; Villar Z MJ; Orellana C C; González R J; Montenegro U C
    Rev Chilena Infectol; 2006 Sep; 23(3):215-9. PubMed ID: 16896493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.